These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 30328028
1. Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats. Zhou Y, Wang H, Man F, Guo Z, Xu J, Yan W, Li J, Pan Q, Wang W. Cardiovasc Drugs Ther; 2018 Dec; 32(6):541-552. PubMed ID: 30328028 [Abstract] [Full Text] [Related]
2. Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy. Wang H, Zhou Y, Guo Z, Dong Y, Xu J, Huang H, Liu H, Wang W. J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):66-78. PubMed ID: 28618859 [Abstract] [Full Text] [Related]
3. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking. Ramírez E, Picatoste B, González-Bris A, Oteo M, Cruz F, Caro-Vadillo A, Egido J, Tuñón J, Morcillo MA, Lorenzo Ó. Cardiovasc Diabetol; 2018 Jan 11; 17(1):12. PubMed ID: 29325553 [Abstract] [Full Text] [Related]
6. Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat). Mega C, de Lemos ET, Vala H, Fernandes R, Oliveira J, Mascarenhas-Melo F, Teixeira F, Reis F. Exp Diabetes Res; 2011 Jan 11; 2011():162092. PubMed ID: 22203828 [Abstract] [Full Text] [Related]
13. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes. Ramírez E, Klett-Mingo M, Ares-Carrasco S, Picatoste B, Ferrarini A, Rupérez FJ, Caro-Vadillo A, Barbas C, Egido J, Tuñón J, Lorenzo Ó. Cardiovasc Diabetol; 2013 Nov 21; 12():172. PubMed ID: 24261558 [Abstract] [Full Text] [Related]
14. Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model. Gonçalves A, Leal E, Paiva A, Teixeira Lemos E, Teixeira F, Ribeiro CF, Reis F, Ambrósio AF, Fernandes R. Diabetes Obes Metab; 2012 May 21; 14(5):454-63. PubMed ID: 22151893 [Abstract] [Full Text] [Related]
16. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor. Ye Y, Bajaj M, Yang HC, Perez-Polo JR, Birnbaum Y. Cardiovasc Drugs Ther; 2017 Apr 21; 31(2):119-132. PubMed ID: 28447181 [Abstract] [Full Text] [Related]